Saliva Molecular Markers Offer Non-Invasive Prediction of Cancer, Heart Disease, and Parkinson's Risk

New research reveals saliva contains genetic markers that could predict the risk of developing cancer, heart disease, and Parkinson's through non-invasive testing, advancing early diagnosis and personalized medicine.
Researchers from the University of the Basque Country have uncovered a groundbreaking use of saliva as a diagnostic tool for systemic diseases. By analyzing saliva samples from over 350 individuals, the team identified hundreds of molecular markers—specifically genetic polymorphisms (SNPs)—that can signal an increased risk of developing major health conditions such as cancer, cardiovascular diseases, diabetes, and neurodegenerative disorders like Parkinson’s. Their findings, published in npj Genomic Medicine, demonstrate that saliva, a readily accessible biological fluid, harbors genetic information capable of reflecting systemic health states.
The study highlights that these genetic polymorphisms act as biological switches, turning specific genes on or off, which influences disease susceptibility. When comparing their data with global genetic studies, the scientists observed that many of these saliva-based markers are associated with higher risks for common diseases such as prostate cancer, coronary artery disease, Parkinson's, and Type 2 diabetes. Notably, using advanced statistical models, the researchers showed that these markers can explain a significant portion of the genetic heritability of these conditions, often with greater accuracy than traditional blood-based indicators.
Professor José Ramón Bilbao emphasized the underutilized potential of saliva in clinical practice, noting that saliva is one of the most accessible biological fluids. This research paves the way for the development of non-invasive, saliva-based diagnostic tests for early disease detection and ongoing health monitoring, eliminating the need for invasive procedures like blood draws. Another major contribution is the creation of an extensive, open-access database of genetic saliva data, intended to foster further research and innovation across biomedical fields.
While further validation in larger populations is necessary, this pioneering work suggests a future where early detection and personalized medicine could be significantly transformed using saliva as a diagnostic medium, making health assessments more accessible and less invasive. The findings underscore the incredible diagnostic potential hidden in everyday biological samples, opening new avenues for preventive healthcare.
Source: https://medicalxpress.com/news/2025-06-saliva-analysis-reveal-cancer-heart.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Altruistic Kidney Donation: Donors to Strangers Fare Just as Well as Those Donating to Loved Ones
Research shows that donors who give kidneys to strangers have outcomes comparable to those donating to loved ones, supporting the safety and ethical acceptance of non-directed altruistic kidney donations.
Lecanemab: A Well-Tolerated Treatment for Early-Stage Alzheimer's Disease in Real-World Settings
Recent studies indicate that lecanemab, an Alzheimer's drug, is safe and well tolerated outside clinical trials, especially when administered in specialized outpatient clinics. The treatment can slow disease progression with minimal risk of severe side effects, particularly in patients with early-stage Alzheimer's.
Link Between Low-Level Arsenic Exposure in Drinking Water and Adverse Birth Outcomes
New research shows that even low levels of arsenic in public drinking water may increase risks of preterm birth and low birth weight, highlighting the need for stricter water safety standards.
Speedballing: Addressing the Dangerous Union of Stimulants and Opioids in Modern Public Health
Speedballing, the hazardous combination of stimulants and opioids, has become a leading cause of overdose deaths in the U.S. Public health initiatives focused on awareness, treatment, and harm reduction are critical to tackling this evolving crisis.